Comparison of the differential effect of participation in breast cancer screening program versus opportunistic screening or symptomatic detection on tumour characteristics

Data de publicação:

Autores da FMUP

  • José Luís Rosas Fougo

    Autor

  • Bárbara Neves Peleteiro

    Autor

Participantes de fora da FMUP

  • Laza V?squez, C
  • Ru? Monn?, M

Unidades de investigação

Abstract

Objectives The success of a breast cancer screening program is highly dependent on adherence. We aimed to compare the differential effect of participation in breast cancer screening program versus opportunistic screening or symptomatic detection on tumour characteristics. Methods We included women referred to our Breast Centre in 2015?2021: 321 from the breast cancer screening group (group 1) and 422 through opportunistic screening or due to symptomatic detection (group 2). We compared data on sociodemographics, breast cancer detection, clinical features and tumour characteristics. Results A total of 10.6% of women in group 1 had breast symptoms and 63.8% had breast signs, with group 2 presenting higher proportions (57.6 and 77.8%, respectively, P < 0.001). The median tumour size in group 1 was smaller compared with group 2 (14 vs 17 mm, P < 0.001). A total of 8.7% of women in group 1 had nodal involvement whereas in group 2 the proportion corresponded to 19.0% (P < 0.001). No women in group 1 were diagnosed with metastasis, while metastases were found in 2.4% of those from group 2 (P = 0.005). There were no significant differences in molecular subtype of invasive tumours between the two groups. Conclusion The tumour characteristics of women who participated in the breast cancer screening program showed in almost all characteristics more favourable results in comparison with the group who underwent opportunistic screening or sought care due to symptoms. The lower clinical stage observed in those referred from the organised program reaffirms that it is an effective measure for early detection, diagnosis, and treatment. Copyright ? 2024 Wolters Kluwer Health, Inc. All rights reserved.

Dados da publicação

ISSN/ISSNe:
1473-5709, 0959-8278

EUROPEAN JOURNAL OF CANCER PREVENTION  Lippincott Williams and Wilkins Ltd.

Tipo:
Article
Páginas:
-

Documentos

  • Não há documentos

Métricas

Filiações

Filiações não disponíveis

Proyectos asociados

Registry of Local Recurrences After Breast-conserving Surgery in Portugal and Spain (R_ReLoCC) - NCT05406661

Investigador Principal: Diana Maria Oliveira Goncalves

Estudo Observacional Académico (R_ReLoCC) . 2023

Initial experience with Targeted Axillary Dissection after Neoadjuvant Therapy in breast cancer patients

Investigador Principal: José Luís Rosas Fougo

Estudo Clínico Académico . 2022

Assessment of the quality of care provided to patients with breast cancer after conservative treatment using the BREAST-Q®

Investigador Principal: José Luís Rosas Fougo

Estudo Clínico Académico . 2022

Citar a publicação

Partilhar a publicação